292 related articles for article (PubMed ID: 26391088)
1. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links.
He Q; Wang Z; Liu G; Daneshgari F; MacLennan GT; Gupta S
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):7-13. PubMed ID: 26391088
[TBL] [Abstract][Full Text] [Related]
2. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males.
Heo JE; Kim DG; Yoo JW; Lee KS
Aging Male; 2023 Dec; 26(1):6-12. PubMed ID: 36633207
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and male lower urinary tract symptoms.
Ineichen GB; Burkhard FC
Panminerva Med; 2022 Sep; 64(3):329-336. PubMed ID: 34859639
[TBL] [Abstract][Full Text] [Related]
7. Erectile Dysfunction and Lower Urinary Tract Symptoms.
De Nunzio C; Roehrborn CG; Andersson KE; McVary KT
Eur Urol Focus; 2017 Oct; 3(4-5):352-363. PubMed ID: 29191671
[TBL] [Abstract][Full Text] [Related]
8. Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model.
He Q; Babcook MA; Shukla S; Shankar E; Wang Z; Liu G; Erokwu BO; Flask CA; Lu L; Daneshgari F; MacLennan GT; Gupta S
Prostate; 2016 Aug; 76(11):964-76. PubMed ID: 27040645
[TBL] [Abstract][Full Text] [Related]
9. Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.
Russo GI; Castelli T; Urzì D; Privitera S; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
Int J Urol; 2015 Nov; 22(11):982-90. PubMed ID: 26193757
[TBL] [Abstract][Full Text] [Related]
10. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review.
Haghpanah A; Masjedi F; Salehipour M; Hosseinpour A; Roozbeh J; Dehghani A
Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):27-38. PubMed ID: 34007019
[TBL] [Abstract][Full Text] [Related]
11. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
[TBL] [Abstract][Full Text] [Related]
12. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
[TBL] [Abstract][Full Text] [Related]
14. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
[TBL] [Abstract][Full Text] [Related]
15. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
Sebastianelli A; Gacci M
Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
[TBL] [Abstract][Full Text] [Related]
16. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
17. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
[TBL] [Abstract][Full Text] [Related]
18. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
Inamura S; Ito H; Shinagawa T; Tsutsumiuchi M; Taga M; Kobayashi M; Yokoyama O
Prostate; 2018 Jul; 78(10):743-752. PubMed ID: 29608020
[TBL] [Abstract][Full Text] [Related]
19. [Lower urinary tract symptoms related to benign prostatic hyperplasia and erectile dysfunction: A systematic review].
Peyronnet B; Seisen T; Phé V; Misrai V; de la Taille A; Rouprêt M
Presse Med; 2017 Mar; 46(2 Pt 1):145-153. PubMed ID: 27745762
[TBL] [Abstract][Full Text] [Related]
20. The role of prostate inflammation and fibrosis in lower urinary tract symptoms.
Bushman WA; Jerde TJ
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F817-F821. PubMed ID: 27440781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
